Invitrogen™ Rat IL-17F ELISA Kit

Ref.: BL-RE-091733Manufacturer ref.: ERA25RBX5 5 x 96 tests
€2,950.00 excl. VAT

Rat IL-17F quantitates rat IL-17F in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat IL-17F.

Accession number
C87042; CANDF6; cytokine ML-1; IL17F; IL-17 F; IL-24; ILN; interleukin; interleukin 17F; interleukin 17F; interleukin-17F; interleukin-24; ML1; ML-1; IL-17 F mutant
Dose range
0.41 to 100 ng/ml
Sensitivity of the dosage
0.41 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Rat IL-17F quantitates rat IL-17F in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat IL-17F.

Rat IL-17F quantitates rat IL-17F in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat IL-17F.

The IL-17F (Interleukin 17F, CTLA-8) is a cytokine belonging to the IL-17 family produced by inflammatory cells such as activated T cells, mastocytes and basophiles. The IL-17F is involved in allergic inflammation of the respiratory tract and can induce several cytokines, chemokines, and adhesion molecules in bronchial epithelial cells, vein endothelial cells, fibroblasts, and eosinophils. The Il-17F may be secreted as a homodimer or heterodimer with the IL17A. It acts by binding to the Type I receptor, IL-17R, facilitating the recruitment of monocytes and neutrophils at the inflammation site by increasing the production of chemokines. The IL-17F also stimulates the induction of other pro-inflammatory cytokines TNF alpha, IL-1 beta, IL-6 and IL-8. Reports strongly suggest the involvement of IL-17 in several chronic inflammatory diseases such as rheumatoid arthritis, psoriasis and multiple sclerosis. TGF-beta (differentiation) and l-IL-23 (expansion) are necessary for the induction and maintenance of Th17 cells (producers d-IL-17), which in turn induce other pro-inflammatory cytokines. The IL-17F is produced and exists, as a homodomer, with an early protein of the herpes virus. It is one of the six members (IL-17A-F) of this cytokine family, and is well characterized and strongly expressed by activated memory T cells. The IL-17F has been found to inhibit endothelial cell genesis and induce endothelial cells to produce the IL2, TGFB1/TGFB, and the chemotactic protein of type 1 monocytes.

Sensitivity

Sensitivity of dosage: 0.41 ng/ml.

Measurement range

Dose range: 0.41 to 100 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: IL-17 F.

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17175859
Specifications
Accession numberC87042; CANDF6; cytokine ML-1; IL17F; IL-17 F; IL-24; ILN; interleukin; interleukin 17F; interleukin 17F; interleukin-17F; interleukin-24; ML1; ML-1; IL-17 F mutant
Dose range0.41 to 100 ng/ml
Sensitivity of the dosage0.41 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q5BJ95
Gene symbol(s)IL17F
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetIL-17 F
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 µl; plasma, 50 µl; serum, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.ERA25RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.